LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

Search

Quidel Corp

Fermé

15.21 -8.43

Résumé

Variation du prix de l'action

24h

Actuel

Min

15.04

Max

15.53

Chiffres clés

By Trading Economics

Revenu

602M

-131M

Ventes

24M

724M

Marge bénéficiaire

-18.062

Employés

6,500

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+101.77% upside

Dividendes

By Dow Jones

Prochains Résultats

6 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-172M

1B

Ouverture précédente

23.64

Clôture précédente

15.21

Quidel Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

22 mars 2026, 23:50 UTC

Market Talk

Global Equities Roundup: Market Talk

22 mars 2026, 23:50 UTC

Market Talk

LG Electronics Set to Stage Strong Earnings Rebound in 1Q -- Market Talk

22 mars 2026, 23:49 UTC

Market Talk
Principaux Événements d'Actualité

Gold Edges Lower on Prospects of Liquidity-Driven Sales -- Market Talk

22 mars 2026, 23:49 UTC

Market Talk
Principaux Événements d'Actualité

Nikkei May Fall as Concerns About Middle East Conflict Persist -- Market Talk

22 mars 2026, 23:49 UTC

Market Talk
Principaux Événements d'Actualité

Global Forex and Fixed Income Roundup: Market Talk

22 mars 2026, 23:41 UTC

Market Talk
Principaux Événements d'Actualité

Oil Edges Lower as Traders Eye Trump's Deadline to Reopen Strait of Hormuz -- Market Talk

22 mars 2026, 22:57 UTC

Acquisitions, Fusions, Rachats

Perseus Mining: Location of Aurum's Discoveries Present Potential Future Synergies

22 mars 2026, 22:56 UTC

Acquisitions, Fusions, Rachats

Perseus Mining: Aurum Share Acquisition Cost A$23.69 Million

22 mars 2026, 22:56 UTC

Acquisitions, Fusions, Rachats

Perseus Mining: Aurum's Boundiali Gold Project Located to South of Sissingue Gold Mine

22 mars 2026, 22:55 UTC

Acquisitions, Fusions, Rachats

Perseus Mining: Participated in Aurum Resources Equity Raising

22 mars 2026, 22:54 UTC

Acquisitions, Fusions, Rachats

Perseus Mining: Acquires 9.9% Interest in Aurum Resources

22 mars 2026, 22:22 UTC

Market Talk
Principaux Événements d'Actualité

After Selloff, Gold Seen Supported by Strait of Hormuz Deadline -- Market Talk

22 mars 2026, 22:06 UTC

Acquisitions, Fusions, Rachats

Synopsys Has Market Value Over $80 Billion; Major Customers Include Nvidia -- WSJ

22 mars 2026, 22:06 UTC

Acquisitions, Fusions, Rachats

Activist Elliott Builds Big Stake in Chip-Design Software Maker Synopsys -- WSJ

22 mars 2026, 22:06 UTC

Acquisitions, Fusions, Rachats

Activist Elliott Investment Management Has Multibillion-Dollar Investment in Synopsys, Sources Say -- WSJ

22 mars 2026, 22:06 UTC

Acquisitions, Fusions, Rachats

Elliott Plans to Push Synopsys to Make More Money From Its Software and Services, Sources Say -- WSJ

22 mars 2026, 21:53 UTC

Résultats

Zijin Gold International Plans 59.2 Tons of Gold Production in 2026; up 12.3% on Year >2259.HK

22 mars 2026, 21:53 UTC

Résultats

Zijin Gold International Rising Gold Prices Supported Results >2259.HK

22 mars 2026, 21:53 UTC

Résultats

Zijin Gold International 2025 Rev $5.38B Vs. $2.99B >2259.HK

22 mars 2026, 21:53 UTC

Résultats

Zijin Gold International 2025 Net $1.60B Vs. Net $481.37M >2259.HK

22 mars 2026, 21:31 UTC

Résultats

China Petroleum & Chemical Plans CNY131.6B-CNY148.6B Capex Spending in 2026>0386.HK

22 mars 2026, 21:31 UTC

Résultats

China Petroleum & Chemical: Decrease in Sales Volumes of Refined Oil Products Also Hurt Results >0386.HK

22 mars 2026, 21:31 UTC

Résultats

China Petroleum & Chemical 2025 Results Weighed by Decrease in Prices of Petroleum, Petrochemical Products>0386.HK

22 mars 2026, 21:31 UTC

Résultats

China Petroleum & Chemical 2025 Rev CNY2.78T Vs. CNY3.07T >0386.HK

22 mars 2026, 21:31 UTC

Résultats

China Petroleum & Chemical 2025 Net CNY32.48B Vs. Net CNY48.94B >0386.HK

22 mars 2026, 21:25 UTC

Market Talk
Principaux Événements d'Actualité

Bonds Decoupling From Oil Amid Longer Conflict Fears -- Market Talk

22 mars 2026, 21:22 UTC

Acquisitions, Fusions, Rachats

St Barbara: Remarks Follow Recent Inquiries About Simberi's Fuel Stocks

22 mars 2026, 21:21 UTC

Acquisitions, Fusions, Rachats

St Barbara: Simberi Currently Uses About 65,000 Liters Per Day For Mining Fleet, Power Generation

22 mars 2026, 21:21 UTC

Market Talk

Revised Fuel Subsidy Mechanism Positive for Ampol, Viva Energy -- Market Talk

22 mars 2026, 21:21 UTC

Acquisitions, Fusions, Rachats

St Barbara: Has Been Taking Precaution to Increase Diesel Storage For Several Months

Comparaison

Variation de prix

Quidel Corp prévision

Objectif de Prix

By TipRanks

101.77% hausse

Prévisions sur 12 Mois

Moyen 30.75 USD  101.77%

Haut 38 USD

Bas 25 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

5 ratings

1

Achat

3

Maintien

1

Vente

Éléments financiers

Frais Généraux et Administratifs

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

Bénéfice d'exploitation

$

À Propos Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat